HWM
RCKT icon

HB Wealth Management’s Rocket Pharmaceuticals RCKT Stock Holding History

HB Wealth Management’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36K Buy
+10,541
New +$35.1K ﹤0.01% 1686

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

HB Wealth Management's RCKT Position: Q2 2026 in Review

HB Wealth Management opened a new position in Rocket Pharmaceuticals (RCKT) in Q2 2026: 10,541 shares worth $36K. The stake represents ﹤0.01% of the portfolio and ranks #1686 among its holdings.

180 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • HB Wealth Management held 10,541 shares of Rocket Pharmaceuticals worth $36K as of Q2 2026.
  • Rocket Pharmaceuticals was a new HB Wealth Management position in Q2 2026.
  • Rocket Pharmaceuticals made up ﹤0.01% of HB Wealth Management's portfolio in Q2 2026, its #1686 holding.
  • 180 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on HB Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.